FOLD Amicus Therapeutics Inc

USD 10.43 0.44 4.404404
Icon

Amicus Therapeutics Inc (FOLD) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 10.43

+0.44 (+4.40)%

USD 3.04B

3.98M

USD 15.00(+43.82%)

USD 17.50 (+67.79%)

Icon

FOLD

Amicus Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 10.43
0.00 0
Take a Tour

Amicus Therapeutics Inc (FOLD) Stock Forecast

Show ratings and price targets of :
USD 15.00
(+43.82%)

Based on the Amicus Therapeutics Inc stock forecast from 1 analysts, the average analyst target price for Amicus Therapeutics Inc is USD 15.00 over the next 12 months. Amicus Therapeutics Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Amicus Therapeutics Inc is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Amicus Therapeutics Inc’s stock price was USD 10.43. Amicus Therapeutics Inc’s stock price has changed by -1.04% over the past week, -11.23% over the past month and -12.35% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...